Michael Reitermann serves as Member Board of Directors at Alpha-9 Oncology, based in New York, New York. Their role sits in the C-Suite function at the C-Suite level. Alpha-9 Oncology is a private company in the Biotechnology Research industry, with 100 to 250 employees, founded in 2019.
Michael Reitermann currently holds the position of Member Board of Directors at Alpha-9 Oncology. The position falls within the C-Suite function at the C-Suite level. It is based in New York, New York, in the Biotechnology Research industry.
Looking for a different Michael Reitermann
Search 300M+ verified professional contacts globally
Capture and validate leads instantly on LinkedIn Sales Navigator.
Turn every profile into a high-quality lead opportunity with real-time verified data via the ReachStream Chrome Extension.

Looking for a different Michael Reitermann
Search 300M+ verified professional contacts globally